Millendo Therapeutics Announces Appointment of Christopher J. Seiter as Chief Financial Officer
November 17, 2016 at 07:00 am EST
Millendo Therapeutics, Inc. announced the appointment of Christopher J. Seiter as its Chief Financial Officer. Mr. Seiter will join Millendo’s senior management team and will be responsible for the finance, treasury and accounting functions of the Company. Prior to joining Millendo, Mr. Seiter served as a Managing Director at Bank of America Merrill Lynch in the firm’s healthcare investment banking group.